Pulmonary alveolar type I cell population consists of two distinct subtypes that differ in cell fate

Proceedings of the National Academy of Sciences of the United States of America
Yanjie WangNan Tang

Abstract

Pulmonary alveolar type I (AT1) cells cover more than 95% of alveolar surface and are essential for the air-blood barrier function of lungs. AT1 cells have been shown to retain developmental plasticity during alveolar regeneration. However, the development and heterogeneity of AT1 cells remain largely unknown. Here, we conducted a single-cell RNA-seq analysis to characterize postnatal AT1 cell development and identified insulin-like growth factor-binding protein 2 (Igfbp2) as a genetic marker specifically expressed in postnatal AT1 cells. The portion of AT1 cells expressing Igfbp2 increases during alveologenesis and in post pneumonectomy (PNX) newly formed alveoli. We found that the adult AT1 cell population contains both Hopx+Igfbp2+ and Hopx+Igfbp2- AT1 cells, which have distinct cell fates during alveolar regeneration. Using an Igfbp2-CreER mouse model, we demonstrate that Hopx+Igfbp2+ AT1 cells represent terminally differentiated AT1 cells that are not able to transdifferentiate into AT2 cells during post-PNX alveolar regeneration. Our study provides tools and insights that will guide future investigations into the molecular and cellular mechanism or mechanisms underlying AT1 cell fate during lung development and regeneration.

References

Dec 21, 1977·Biochimica Et Biophysica Acta·V Oldenborg, L M Van Golde
Feb 1, 1992·American Journal of Respiratory Cell and Molecular Biology·K C StoneJ D Crapo
Oct 1, 1985·The Journal of Clinical Investigation·D MassaroP Whitney
Feb 9, 2000·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·T J CapernaR Vasilatos-Younken
Mar 7, 2002·American Journal of Physiology. Lung Cellular and Molecular Physiology·Zea BorokEdward D Crandall
Nov 13, 2002·Annual Review of Physiology·Mary C Williams
Feb 26, 2003·American Journal of Respiratory Cell and Molecular Biology·Renli QiaoZea Borok
Oct 2, 2004·The European Respiratory Journal·M C McElroy, M Kasper
Feb 9, 2005·Current Opinion in Pulmonary Medicine·Andrew Churg, Joanne L Wright
Apr 9, 2005·Pediatric Research·Jacques BourbonChristophe Delacourt
Nov 23, 2007·American Journal of Physiology. Lung Cellular and Molecular Physiology·Johannes C SchittnyMarco Stampanoni
Jul 25, 2008·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Sonja I MundJohannes C Schittny
Jan 8, 2010·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Leland G DobbsRobert Gonzalez
Nov 30, 2011·Proceedings of the National Academy of Sciences of the United States of America·Jason R RockBrigid L M Hogan
Mar 27, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Julia Yue CuiCurtis D Klaassen
Apr 24, 2012·Nature Cell Biology·Francesco NiolaAnna Lasorella
Aug 8, 2013·The Journal of Clinical Investigation·Christina E BarkauskasBrigid L M Hogan
Jan 21, 2014·Nature Reviews. Cancer·Anna LasorellaAntonio Iavarone
Jun 8, 2014·American Journal of Physiology. Lung Cellular and Molecular Physiology·Matt J HerringDallas M Hyde
Apr 14, 2015·Nature Communications·Rajan JainJonathan A Epstein
Nov 21, 2015·Development·Jun YangJichao Chen
Dec 4, 2015·Developmental Biology·Kelsey BranchfieldXin Sun

❮ Previous
Next ❯

Citations

Sep 29, 2018·Respirology : Official Journal of the Asian Pacific Society of Respirology·Daniel C ChambersJoseph E Powell
Dec 7, 2018·The Journal of Pathology·Svenja LoeringPhilip M Hansbro
Sep 29, 2018·The European Respiratory Journal·Konstantinos GkatzisSaverio Bellusci
Mar 23, 2019·Expert Opinion on Biological Therapy·Jonathan L McQualter
Aug 2, 2019·American Journal of Respiratory Cell and Molecular Biology·Robert M TigheAlexander V Misharin
Oct 18, 2019·The European Respiratory Journal·Soula DanopoulosDenise Al Alam
Aug 14, 2020·PLoS Pathogens·Elizabeth J FayRyan A Langlois
Sep 25, 2019·Proceedings of the National Academy of Sciences of the United States of America·Danielle R LittleJichao Chen
Sep 30, 2020·Nature Cell Biology·Andrew J ParisG Scott Worthen
Jul 25, 2018·American Journal of Respiratory Cell and Molecular Biology·Carolina Garcia-de-AlbaCarla F Kim
Jul 17, 2018·American Journal of Respiratory Cell and Molecular Biology·Mei-I Chung, Brigid L M Hogan
Feb 21, 2019·Proceedings of the National Academy of Sciences of the United States of America·David B FrankEdward E Morrisey
Jul 20, 2019·Science China. Life Sciences·Tingting LvChen Wang
Oct 10, 2019·American Journal of Physiology. Lung Cellular and Molecular Physiology·Ettore LignelliRory E Morty
Feb 14, 2020·Current Stem Cell Research & Therapy·Saba SameriRazieh Amini
Aug 14, 2020·International Journal of Molecular Sciences·Amnah SharifRodrigo Fernandez-Valdivia
Dec 14, 2019·Advanced Science·Shumsuzzaman KhanXuequn Chen
Apr 8, 2020·Stem Cells International·Yu LiHuaiyong Chen
Feb 6, 2020·American Journal of Physiology. Lung Cellular and Molecular Physiology·Yves DonatiConstance Barazzone-Argiroffo
Oct 11, 2020·The Journal of Experimental Biology·Laura Cadiz, Michael G Jonz
Nov 11, 2020·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Lisandra Vila Ellis, Jichao Chen
Dec 15, 2020·Advanced Drug Delivery Reviews·Carlos Cruz-TeranSamuel K Lai
Jan 20, 2021·Development·Huijuan Wu, Nan Tang
Feb 1, 2021·Stem Cell Research & Therapy·Jing KongFukai Bao
Oct 30, 2020·Frontiers in Cell and Developmental Biology·Zhao Ni Wang, Xiao Xiao Tang
Jan 12, 2021·Molecular Therapy. Methods & Clinical Development·Altar M MunisDeborah R Gill
Mar 29, 2021·Pharmacology & Therapeutics·Gang LiuPhilip M Hansbro
Apr 13, 2021·Frontiers in Pharmacology·Pamela Velázquez-DíazYang Zhou
Apr 16, 2021·Communications Biology·Giorgia MaroniElena Levantini

❮ Previous
Next ❯

Methods Mentioned

BETA
RNA-seq
FACS
scRNA-seq

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Cell Fate Conversion By mRNA

mRNA-based technology is being studied as a potential technology that could be used to reprogram cell fate. This technique provides the potential to generate safe reprogrammed cells that can be used for clinical applications. Here is the latest research on cell fate conversion by mRNA.